Miotin is a synthetic anticholinesterase agent within the carbamate class, historically significant as the first drug of this type used clinically to treat myasthenia gravis and other neuromuscular disorders.… Read more
Miotin is a synthetic anticholinesterase agent within the carbamate class, historically significant as the first drug of this type used clinically to treat myasthenia gravis and other neuromuscular disorders. Laboratories and researchers rely on high-quality reference standards for Miotin, as well as its related impurities and metabolites, to conduct rigorous analytical testing and quality control. These materials are essential for accurate impurity profiling and method validation during pharmaceutical development, ensuring that drug formulations meet regulatory requirements. Stable isotope labelled compounds, such as Miotin-13C-d3, are particularly valuable in mass spectrometry applications, serving as internal standards to improve precision and sensitivity in quantitation. Access to these specialized compounds supports the ongoing characterization of Miotin derivatives and the maintenance of rigorous standards in pharmacological studies.